Requests that the FDA initiate rulemaking to switch hydroxychloroquine sulfate (HCQ) oral tablet products from prescription-only status to full over-the-counter status.
🏛 Food and Drug Administration (FDA)FDA-2025-P-1982
Documents
1
Total comments
331
1 awaiting analysis
Comment status
Open
Last activity
Jul 25, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Other· Jun 27, 2025No comment period💬 331